(2S,3S,4S,5R,6S)-6-(4-((2S,3R)-1-(4-Fluorophenyl)-3-((S)-3-(4-Fluorophenyl)-3-Hydroxypropyl)-4-Oxoazetidin-2-Yl)Phenoxy)-3,4,5-Trihydroxytetrahydro-2H-Pyran-2-Carboxylic Acid (2S,3S,4S,5R,6S)-6-(4-((2S,3R)-1-(4-氟苯基)-3-((S)-3-(4-氟苯)-3-羟丙基)-4-氧代氮杂环丁烷-2-基)苯氧基)-3,4,5-三羟基四氢-2H-吡喃-2-羧酸
CAS 190448-57-8 MFCD08063721
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Lee DH, et al. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Free Radic Biol Med. 2016 Sep 12;99:520-532.
- [1]. Stolk MF, et al. Severe hepatic side effects of ezetimibe. Clin Gastroenterol Hepatol. 2006 Jul;4(7):908-11.
- [1]. Stolk MF, et al. Severe hepatic side effects of ezetimibe. Clin Gastroenterol Hepatol. 2006 Jul;4(7):908-11.
- [2]. Lee DH, et al. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Free Radic Biol Med. 2016 Sep 12;99:520-532.
安全信息
GHS Symbol
